Skip to content

Net margin at other companies

Baxter International logo
Baxter InternationalBAX
-9.7%+62.5pp
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
15.2%+1.0pp
ADMA Biologics logo
ADMA BiologicsADMA
32.4%-12.6pp
Medpace Holdings, Inc. logo
Medpace Holdings, Inc.MEDP
17.2%-2.1pp
Biodesix, Inc. logo
Biodesix, Inc.BDSX
-33.3%-9.3pp
ClearPoint Neuro logo
ClearPoint NeuroCLPT
-71.6%+8.8pp

Other financials

Income statement

See full
Revenue$23.2M-36.4%
Gross profit$4.5M-68.1%
Operating income-$4.7M
Net income-$15.0M-1,206%
EPS (diluted)-$0.43-1,333%

Balance sheet

See full
Cash & equivalents$20.8M+152%
Total debt$156.9M+1,310%
Total equity-$28.4M-2,229%
Total assets$225.5M-5.8%

Cash flow

See full
Operating cash flow$4.7M
CapEx$1.1M-46.7%
Free cash flow$3.6M

Valuation

See full
Market cap$196.92M-35.4%
Enterprise value$333.06M+8.3%
P/S1.6×+0.5×

Profitability

See full
Gross margin31.3%-1.4pp
Operating margin-14.5%-2.2pp
FCF margin-36.4%

Returns & leverage

See full
Return on equity-612.1%
Debt / equity8.3×-1.5×
Current ratio3.8×+0.9×

Where this comes from

Calculated from Lifecore Biomedical, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Lifecore Biomedical, Inc.’s 10-Q, filed November 6, 2025, on SEC EDGAR. View the filing →

Ask your AI about Lifecore Biomedical, Inc.'s net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lifecore Biomedical, Inc.'s net margin?
Lifecore Biomedical, Inc. (LFCR) reported net margin of -30% in Q1 2025.
What is the long-term trend for Lifecore Biomedical, Inc.'s net margin?
Over 3 years (2021 to 2025), Lifecore Biomedical, Inc.'s net margin has grown at a 3.5% compound annual growth rate (CAGR), from -27.1% to -30%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.